1.<strong>Xu Y</strong>, Evans M, Mazhar F, et al. Poor recognition and undertreatment of anemia in patients with chronic kidney disease managed in primary care. Journal of Internal Medicine. 2023;00:1-12. (JCR Q1)

2.<strong>Xu Y</strong>, Dong S, Fu EL, Sj？lander A, Grams ME, Selvin E, Carrero JJ: Long-term Visit-to-Visit Variability in Hemoglobin A(1c) and Kidney-Related Outcomes in Persons With Diabetes. American journal of kidney diseases: the official journal of the National Kidney Foundation 2023;82(3):254-256. (JCR Q1, top 5 journals in Nephrology)

3.Weng L#, <strong>Xu Y#</strong>, Yin P#, Wang Y, Chen Y, Liu W, Li S, Peng JM, Dong R, Hu XY, Jiang W, Wang CY, Gao P, Zhou MG, Du B and for the China Critical Care Clinical Trials G. National incidence and mortality of hospitalized sepsis in China. Critical Care.2023;27:84. (JCR Q1, top 5 journals in Critical Care and Intensive Care Medicine)

4.<strong>Xu Y#*</strong>, Fu EL#, Clase CM, Mazhar F, Jardine MJ, Carrero JJ. GLP-1 receptor agonist versus DPP-4 inhibitor and kidney and cardiovascular outcomes in clinical practice in type-2 diabetes. Kidney international 2022;101:360-368 (JCR Q1, top 5 journals in Nephrology)

5.<strong>Xu Y</strong>, Fu EL, Trevisan M, Jernberg T, Sj？lander A, Clase CM, Carrero JJ. Stopping renin-angiotensin system inhibitors after hyperkalemia and risk of adverse outcomes. American heart journal 2022;243:177-186 (JCR Q1)

6.<strong>Xu Y#</strong>, Li L#, Evans M, Xu H, Lindholm B, Carrero JJ. Burden and causes of hospital admissions and readmissions in patients undergoing hemodialysis and peritoneal dialysis: a nationwide study. Journal of nephrology 2021;34:1949-1959 (JCR Q1)

7.<strong>Xu Y</strong>, Evans M, Soro M, Barany P, Carrero JJ. Secondary hyperparathyroidism and adverse health outcomes in adults with chronic kidney disease. Clin Kidney J 2021;14:2213-2220 (JCR Q1)

8.<strong>Xu Y</strong>, Evans M, Barany P, James G, Sj？lander A and Carrero JJ. Factors affecting pre-end-stage kidney disease haemoglobin control and outcomes following dialysis initiation: a nationwide study. Clin Kidney J. 2021;14:1780-1788 (JCR Q1)

9.<strong>Xu Y*</strong>, Surapaneni A, Alkas J, Evans M, Shin J-I, Selvin E, Chang A, Grams ME, Carrero JJ. Glycemic Control and the Risk of Acute Kidney Injury in Patients With Type 2 Diabetes and Chronic Kidney Disease: Parallel Population-Based Cohort Studiesin U.S. and Swedish Routine Care. Diabetes Care 2020;43:2975-2982 (JCR Q1, top 5 journals in Endocrinology, Diabetes and Metabolism)

10.<strong>Xu Y</strong>, Wang T, Yang Z, Lin H, Shen P, Zhan S. Sulphonylureas monotherapy and risk of hospitalization for heart failure in patients with type 2 diabetes mellitus: A population-based cohort study in China. Pharmacoepidemiology and Drug Safety 2020;29:635-643 (JCR Q2)
